Search Images Maps Play YouTube News Gmail Drive More »
Sign in
Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader.


  1. Advanced Patent Search
Publication numberUS979993 A
Publication typeGrant
Publication dateDec 27, 1910
Publication numberUS 979993 A, US 979993A, US-A-979993, US979993 A, US979993A
Export CitationBiBTeX, EndNote, RefMan
External Links: USPTO, USPTO Assignment, Espacenet
US 979993 A
Previous page
Next page
Description  (OCR text may contain errors)




979,993. Patented Dec. 27, 1910.


Specification of Letters latent Patented Dec. 27,1919.

Application filed March 24, 1910. Serial *No; 551,353.

To all whom it may concern.

Be it. known that we, Joanna FRANCIS OBYRNE and THOMAS; A. Fnoon, both citizens of the United States, and residing, respectively, at Contact, in the county of Elko and State of Fevada', and Salt Lake City,

jectiles and consists "in certain novel constru'ctions and combinations of parts as will be hereinafter described and claimed.

In the drawing Figure 1 is a longitudinal section of a rojectile in the form of a cartridge embodying our invention and Fig. 2 is a cross sectional view on about the line 2--2 of Fig. 1. j

This invention is -in the nature of a projectile in the form of a bullet or missile as the case may be, especially designed for use in catching wild animals and .has for an object to provide a projectile carrying a narcotic whoseanesthetic efi'ect will so affect the animal as to render the capture and control of the same easy.

In the construction shown, I provide a projectile with an opening or recess to receive an opiate, or other narcotic or anesthetizing substance and the said recessis shown as opening laterally and it is illustrated in Fig. 2 as annula" in form 'so' an annular body of the substance maybe used and I also illustrate a soluble cover or envelop which may. be of gelatin as more fully described hereinafter.

In the construction shown the projectile is in the form of a bullet B connected with a cartridge D which maybe of the ordinary construction and the bullet B has a point-B, a butt B and an axial shank B connecting the point and butt, the projectile being recessed between the point and butt forming as shown in Fig. 2 an annular recess in which the substance may be'placed and the ends of said recess 0- are undercut at C to aid in retaining the substance when applied as presently described. The substance or chargeA toact as a narcotic may be apornorphine hydrochlorate, or morphine and scopolamin, or the equivalent ofscopolamin, hyoscin', or morphine sulfate, or the hydrochlorate or in fact any of the alkaloids or other substances which will tend to produce sleep or stupor when taken up by thetissues. V

In the case of the larger animals like the elephant and rhinoceros with thick skins, the body of the projectile may be of lead, steel or the -like or other heavy metal while with smaller thin skinned animals some soluble material or such substances as magnesium may be employed as the metalrnag nesium will ordinarily be absorbed byfithe animal tissues in from two to, tour Weeks after entering the same and will leave no trace. This is desirable as it avoids extract the bullet as a. steel bullet 'or steel jacketed bullet will have to be used owing tothe-fact that magnesium will not penetrate due to its low specificgravity. "The cover E s of some soluble substance: preferably gelatin and is in the formofa cylindrical casing fitting between the point and butt of the projectile and coinciding in its external circumference with that oi said point and butt and forms an inclosure: or

envelop retaining the substance A until it has entered the animal.

In operation the animal is .shot in some" fleshy part with a powder charge or other force sufficient to just penetrate the skin or for a short distance into the tissues and melt or dissolve in from ten to fifteen minutes, more or less, and the blood will absorb the substance A and the animal will in from twenty to forty minutes come into the influence of the substance when-it can be easily as Y when in the tissues the gelatin cover will.

captured-and tied up. The drug material A maybe used in the dry form, or if desired in the shape in which it comes for hypodermic injections and when constructed as shown in Figs. 1 and .2 the drug charge is cylindrical or tubular in shape.

The gelatin is employed for strength and to avoid climatic changes in the drug. If

quick action is desired, the gelatin can be is hit by the projectile.

106 knocked off orotherwise removed when the drug will begin to act as soon as the animal calculated for the animals or birds on which" it is designed to use the rojectile and for birds the projectile may e made founder ,and shorter for small rifles.

It is found practice that in to secure a quickaction of the drug charge.

It will be noticed that the cartridge shellextends-at D over the latera opening in the projectile and over the charge and the gelatin cover therefor, when such gelatin cover is employed. .By-extending the cartridge shell over the narcotic charge the dru is protected from the weather by the shell and is also so incased as to prevent mechanical injury or displacement thereof.

a It will be understood that the gelatin cover may or may not be employed, as while it increases the safety and certainty of op eration, it is not really necessary when the drug is protected by the extension ofthe cartridge shell as shown and above described. When the gelatin cover is omitted some suitable binder may be incorporated with or used otherwise with the drug as ordinarily the drug would not be strong enough to stand the shock of leaving the rifle unless held in some way to the projectile.

We claim 1. A projectile having a recess or opening, a narcotic therein and a gelatin like cover for said recess or opening.

2. A projectile having a point, a butt, a connection between the point and the butt and a narcotic between the point and butt and alongside the connection and a gelatinlike cylinder inclosing the narcotic.

3. A. projectile of material adapted to be absorbed by animal tissue and having a point and butt and a central connection bee izvti'een the same and a narcotic between the point and butt and encircling the connection.v i

inclosing the narcotic.

j 3 5. A projectile having a point or butt and a connection between the same of reduced diameter whereby an annular recess is pro- Vided surroundin the connection, the ends of the said recess eingundercut and a narcotic held in said recess. v

6. A projectile of magnesium having a recess or opening and a narcotic therein substantially as described.

7. A projectile of magnesium having a point, a butt spaced therefrom and a relatively smaller connecting portion between the point and butt and a narcotic carried between the point and butt.

8. A projectile of magnesium having a point or'butt, a relatively smaller connecting portion between the same and concentric therewith, a narcotic surrounding said connecting portion between the point and butt and a gelatin cover for the narcotic.

9. A projectile of'magnesium having a laterally openin recess, a narcotic therein and a soluble c osure extending over the said recess.


Witnesses to the signature of Joseph F.



Witnesses to the signature of Thomas A. Flood; I

H. N. MAYO, J. 0. Snow.

rojectile having an annular recess, a narcotic therein and a gelatin like cylinder

Referenced by
Citing PatentFiling datePublication dateApplicantTitle
US3326129 *Sep 1, 1965Jun 20, 1967Bert B GouldMiniature disappearing projectile
US3837284 *Sep 7, 1973Sep 24, 1974Waldeisen RDry charge hypodermic projectile
US3948263 *Aug 14, 1974Apr 6, 1976Minnesota Mining And Manufacturing CompanyBallistic animal implant
US3982536 *Nov 15, 1974Sep 28, 1976Minnesota Mining And Manufacturing CompanyBallistic inoculation of animals and projectile therefor
US6331310Aug 1, 2000Dec 18, 2001Quadrant Holdings Cambridge LimitedSolid dose delivery vehicle and methods of making same
US6565871Aug 31, 2001May 20, 2003Elan Drug Delivery Ltd.For administration of a bioactive material to subcutaneous and intradermal tissue
US6584910Apr 19, 2002Jul 1, 2003David J. PlassAnimal syringe system
US6586006Jan 5, 2001Jul 1, 2003Elan Drug Delivery LimitedVitreous vehicle loaded with guest substance such as drugs, enzymes, vaccines; vehicle allows guest substance to be dried and stored without loss of activity
US6811792Oct 25, 2002Nov 2, 2004Quadrant Drug Delivery Ltd.Solid dose delivery vehicle and methods of making same
US6893657Feb 27, 2003May 17, 2005Quadrant Drug Delivery Ltd.Vehicle for ballistic administration of a bioactive material to subcutaneous and intradermal tissue, the delivery vehicle being sized and shaped for penetrating the epidermis. The delivery vehicle further comprises a stabilizing polyol glass
US7056495Aug 29, 2003Jun 6, 2006Quadrant Drug Delivery Ltd.Vehicle for amorphus drug dose delivery, containing a hydrophobic material and a polyol; dissolving the polyol and hydrophobic bioactive material in an organic/aqueous solvent, removing the solvent and forming the vehicle
US7300919Sep 18, 2002Nov 27, 2007Nektar TherapeuticsPulmonary delivery of active fragments of parathyroid hormone
US7306787Mar 12, 2002Dec 11, 2007Nektar TherapeuticsEngineered particles and methods of use
US7521069Jul 1, 2003Apr 21, 2009Novartis AgMethods and compositions for pulmonary delivery of insulin
US7628978Aug 19, 2003Dec 8, 2009Novartis Pharma AgStabilized preparations for use in metered dose inhalers
US7744925May 20, 2005Jun 29, 2010Quadrant Drug Delivery LimitedInsulin and a sugar alcohol; powder for pulmonary delivery; inhalants; storage stability
US7780991May 20, 2005Aug 24, 2010Quadrant Drug Delivery Limitedfor ballistic administration of a bioactive material to subcutaneous and intradermal tissue, delivery vehicle being sized and shaped for penetrating the epidermis; vehicle further comprises a stabilizing polyol glass, in particular, trehalose
US7785631May 20, 2005Aug 31, 2010Quadrant Drug Delivery LimitedSolid dose delivery vehicle and methods of making same
US7871598May 10, 2000Jan 18, 2011Novartis Agexhibit improved stability and dispersability over the shelf life of the composition; microparticles are simple to produce without the need of the formation of an emulsion or the use of an oil as a blowing agent
US8168223Jun 21, 2001May 1, 2012Novartis Pharma AgEngineered particles and methods of use
US8246934Sep 3, 2010Aug 21, 2012Novartis AgRespiratory dispersion for metered dose inhalers comprising perforated microstructures
US8349294Dec 14, 2010Jan 8, 2013Novartis AgStable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
US8404217Jul 22, 2005Mar 26, 2013Novartis Agantifungal administered via inhalation; good dispersibility and storage stability; efficiently delivered to the deep lung; treating pulmonary aspergillosis with amphotericin B-containing formulations
US8709484Oct 24, 2008Apr 29, 2014Novartis AgPhospholipid-based powders for drug delivery
US8715623Oct 31, 2007May 6, 2014Novartis AgPulmonary delivery of aminoglycoside
USB524121 *Nov 15, 1974Feb 3, 1976 Title not available
DE2603894A1 *Feb 2, 1976Aug 4, 1977Minnesota Mining & MfgBallistisch implantierbarer formkoerper zur gesteuerten wirkstoffabgabe
International ClassificationF42B12/54
Cooperative ClassificationF42B12/54
European ClassificationF42B12/54